alabdy
07-19-2022, 04:08 AM
As 2020 drew to a close, a concerning development in the pandemic came out of Britain — a new variant of the coronavirus had been discovered that is significantly more transmissible. It has since been discovered in a number of countries, including the United States.
The emergence of the new variant has added a new level of urgency to the rollout of vaccines in the U.S., a process that has been slow so far.
Today, an exploration of two key issues in the fight against the pandemic.
Guests: Carl Zimmer (https://www.nytimes.com/by/carl-zimmer), a science writer and author of the “Matter” column for The New York Times; Abby Goodnough (https://www.nytimes.com/by/abby-goodnough), a national health care correspondent for The Times.
For an exclusive look at how the biggest stories on our show come together, subscribe to our newsletter (https://www.nytimes.com/newsletters/the-daily?module=inline). You can read the latest edition here (https://www.nytimes.com/column/the-daily-newsletter).
Background reading:
The new variant of the coronavirus, discovered in December, appears to be more contagious than, and genetically distinct from, more established variants. Here is what we know about it (https://www.nytimes.com/2020/12/31/health/coronavirus-variant-transmission.html).
The first case of the variant in the U.S. was found in Colorado (https://www.nytimes.com/2020/12/29/health/uk-coronavirus-variant-colorado.html) in December. Pfizer has said that its vaccine works (https://www.nytimes.com/2021/01/08/health/pfizer-covid-vaccine-variant-mutation.html) against the key mutation.
The distribution of the vaccine in the U.S. is taking longer than expected (https://www.nytimes.com/2020/12/31/health/vaccine-distribution-delays.html?searchResultPosition=4) — holiday staffing and saving doses for nursing homes are contributing to delays.
For more information on today’s episode, visit nytimes.com/thedaily (http://nytimes.com/thedaily?smid=pc-thedaily)
أكثر... (https://www.nytimes.com/the-daily)
The emergence of the new variant has added a new level of urgency to the rollout of vaccines in the U.S., a process that has been slow so far.
Today, an exploration of two key issues in the fight against the pandemic.
Guests: Carl Zimmer (https://www.nytimes.com/by/carl-zimmer), a science writer and author of the “Matter” column for The New York Times; Abby Goodnough (https://www.nytimes.com/by/abby-goodnough), a national health care correspondent for The Times.
For an exclusive look at how the biggest stories on our show come together, subscribe to our newsletter (https://www.nytimes.com/newsletters/the-daily?module=inline). You can read the latest edition here (https://www.nytimes.com/column/the-daily-newsletter).
Background reading:
The new variant of the coronavirus, discovered in December, appears to be more contagious than, and genetically distinct from, more established variants. Here is what we know about it (https://www.nytimes.com/2020/12/31/health/coronavirus-variant-transmission.html).
The first case of the variant in the U.S. was found in Colorado (https://www.nytimes.com/2020/12/29/health/uk-coronavirus-variant-colorado.html) in December. Pfizer has said that its vaccine works (https://www.nytimes.com/2021/01/08/health/pfizer-covid-vaccine-variant-mutation.html) against the key mutation.
The distribution of the vaccine in the U.S. is taking longer than expected (https://www.nytimes.com/2020/12/31/health/vaccine-distribution-delays.html?searchResultPosition=4) — holiday staffing and saving doses for nursing homes are contributing to delays.
For more information on today’s episode, visit nytimes.com/thedaily (http://nytimes.com/thedaily?smid=pc-thedaily)
أكثر... (https://www.nytimes.com/the-daily)